Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

82P - Interplay of high-risk human papillomaviruses and Epstein-Barr virus in advanced colorectal cancer

Date

27 Jun 2024

Session

Poster Display session

Presenters

Queenie Fernandes

Citation

Annals of Oncology (2024) 35 (suppl_1): S1-S74. 10.1016/annonc/annonc1477

Authors

Q. Fernandes1, S.P. Narayanan2, J.S. Koshy3, I. Gupta1, K. Murshed4, H. Abo Samra4, V.P. Inchakalody5, H. Al-Thawadi1, S. Vranic1, M. Merhi5, M. Petkar4, S. Uddin4, S. Dermime5, G.R. Babu1, A. Al Moustafa1

Author affiliations

  • 1 College of Medicine - Qatar University, Doha/QA
  • 2 Sidra Medical and Research Center, Al-Rayyan/QA
  • 3 QR Medical Center, Al Wakra/QA
  • 4 Hamad Medical Corporation - Hamad General Hospital, Doha/QA
  • 5 Hamad Medical Corporation (HMC) - National Center for Cancer Care and Research (Al Amal Hospital), 3050 - Doha/QA

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 82P

Background

The high-risk human papillomaviruses (HPVs) and the Epstein-Barr virus (EBV) are potent oncoviruses. Yet, their role in colorectal cancer (CRC) is still dubious. This study emerges as the first report on HPV and EBV prevalence/co-prevalence in Qatar and the Gulf Cooperation Council (GCC) region, delineating the link between oncoviral synergy and advance stage CRC. This study aimed to explore co-presence of high-risk HPVs and EBV and their implied cooperation in modulating the expression of epithelial-mesenchymal transition (EMT) biomarkers (fascin/vimentin/epithelial protein lost in neoplasm), that are strongly linked to tumor-progression and metastasis.

Methods

This study analysed 100 tumor samples from CRC patients. Polymerase chain reaction-based genotyping of the oncoviruses was performed. Construction of the tissue microarray was achieved for 80 samples. Immunohistochemical evaluation was carried out to determine the expression levels of the EMT biomarkers. Staining intensity was analysed via a semi-quantitative scoring method. A total score was computed based on the sum of the individual scores for each EMT biomarker. A score ≥ 10 was coded as a high tumor score. Pearson's Chi-square test and logistic regression were calculated to estimate an association between HPV and EBV co-infection and a high tumor score.

Results

High-risk HPVs and EBV are present in 66.2% and 21.2% cases, respectively. Additionally, 16.3% were co-infected with both oncoviruses. The co-infection of high-risk HPVs strongly correlates with advanced stage cancer, and EBV is a strong confounder of this association. In the present investigation, 69.2% of the co-infected samples showed a high score for the expression of EMT biomarkers. Thus, co-infected patients are at 7.2 times greater odds of presenting with a high tumor score (p = 0.002); thereby implying a worse prognosis.

Conclusions

Evidently, the co-infection of oncoviruses is a strong prognostic indicator of advanced stage CRC. Also, oncoviral co-infection can favour EMT, and consequently tumor-progression/metastasis. Further research is essential to confirm the synergistic roles of oncoviruses in the pathogenesis of cancer.

Legal entity responsible for the study

Qatar University.

Funding

Qatar University.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.